High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer

Author:

Fu Hongtao1,Li Kun2,Wang Shui1,Li Yuming3

Affiliation:

1. Department of Breast Surgery, Jiangsu Province Hospital, The First Hospital Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China

2. Department of emergency, Changsha Central Hospital, The Affiliated Changsha Central Hospital of Hengyang Medical School, University of South China, Changsha 410004, China

3. Department of Traditional Chinese Medicine and Western Medicine, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410006, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference36 articles.

1. European cancer mortality predictions for the year 2013.;Negri;Ann Oncol,2013

2. Cancer genome landscapes.;Kinzler;Science,2013

3. functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis.;Xu;Cancer Manag Res,2018

4. CCNB1 is a prognostic biomarker for ER+ breast cancer.;Wang;Med Hypotheses,2014

5. Two distinct controls of mitotic cdk1/cyclin B1 activity requisite for cell growth prior to cell division.;Arai;Cell Cycle,2007

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3